Role of Sp1 in the Induction of p27 Gene Expression in Vascular Smooth Muscle Cells In Vitro and After Balloon Angioplasty
暂无分享,去创建一个
[1] A. Diez-Juan,et al. Control of vascular smooth muscle cell growth by cyclin-dependent kinase inhibitory proteins and its implication in cardiovascular disease. , 2000, Frontiers in bioscience : a journal and virtual library.
[2] S. Meloche,et al. Differential regulation of p27(Kip1) expression by mitogenic and hypertrophic factors: Involvement of transcriptional and posttranscriptional mechanisms. , 2000, The Journal of cell biology.
[3] P. V. van Diest,et al. Cyclin D2 overexpression and lack of p27 correlate positively and cyclin E inversely with a poor prognosis in gastric cancer cases. , 2000, The American journal of pathology.
[4] T. Sakai,et al. Sp1 and NF-Y Synergistically Mediate the Effect of Vitamin D3 in the p27Kip1 Gene Promoter That Lacks Vitamin D Response Elements* , 1999, The Journal of Biological Chemistry.
[5] M. Mann,et al. A novel role for the cyclin-dependent kinase inhibitor p27(Kip1) in angiotensin II-stimulated vascular smooth muscle cell hypertrophy. , 1999, The Journal of clinical investigation.
[6] G. Brooks,et al. Altered expression of cell cycle proteins and prolonged duration of cardiac myocyte hyperplasia in p27KIP1 knockout mice. , 1999, Circulation research.
[7] K. Williams,et al. Atherosclerosis--an inflammatory disease. , 1999, The New England journal of medicine.
[8] M. Dickman,et al. The Mycotoxin Fumonisin B1 Transcriptionally Activates the p21 Promoter through acis-Acting Element Containing Two Sp1 Binding Sites* , 1999, The Journal of Biological Chemistry.
[9] A. Moustakas,et al. Regulation of the human p21/WAF1/Cip1 promoter in hepatic cells by functional interactions between Sp1 and Smad family members. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[10] V. Andrés,et al. Role of c-fos and E2F in the induction of cyclin A transcription and vascular smooth muscle cell proliferation. , 1998, The Journal of clinical investigation.
[11] E. Nabel,et al. Expression of cyclin-dependent kinase inhibitors in vascular disease. , 1998, Circulation research.
[12] S. C. Lin,et al. Molecular characterization of the cyclin-dependent kinase inhibitor p27 promoter. , 1997, Biochimica et biophysica acta.
[13] J. Isner,et al. The biology of restenosis. , 1997, Progress in cardiovascular diseases.
[14] P. Libby,et al. The molecular bases of restenosis. , 1997, Progress in cardiovascular diseases.
[15] E. Ziff,et al. Nerve Growth Factor Induces Transcription of the p21 WAF1/CIP1 and Cyclin D1 Genes in PC12 Cells by Activating the Sp1 Transcription Factor , 1997, The Journal of Neuroscience.
[16] P. Nisen,et al. Downregulation of cyclin-dependent kinase 2 activity and cyclin A promoter activity in vascular smooth muscle cells by p27(KIP1), an inhibitor of neointima formation in the rat carotid artery. , 1997, The Journal of clinical investigation.
[17] A. Takeshita,et al. Adenovirus‐Mediated Transfer of Cyclin‐dependent Kinase Inhibitor‐p21 Suppresses Neointimal Formation in the Balloon‐Injured Rat Carotid Arteries in Vivo a , 1997, Annals of the New York Academy of Sciences.
[18] K. Walsh,et al. Temporally and spatially coordinated expression of cell cycle regulatory factors after angioplasty. , 1997, Circulation research.
[19] M. Loda,et al. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas , 1997, Nature Medicine.
[20] Herman Yeger,et al. Decreased levels of the cell-cycle inhibitor p27Kip1 protein: Prognostic implications in primary breast cancer , 1997, Nature Medicine.
[21] James M. Roberts,et al. Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients , 1997, Nature Medicine.
[22] James M. Roberts,et al. Fibrillar Collagen Inhibits Arterial Smooth Muscle Proliferation through Regulation of Cdk2 Inhibitors , 1996, Cell.
[23] E. Nabel,et al. Role of the p21 cyclin-dependent kinase inhibitor in limiting intimal cell proliferation in response to arterial injury. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[24] J. Biggs,et al. The Role of the Transcription Factor Sp1 in Regulating the Expression of the WAF1/CIP1 Gene in U937 Leukemic Cells (*) , 1996, The Journal of Biological Chemistry.
[25] Xiao-Fan Wang,et al. Functional Analysis of the Transforming Growth Factor βResponsive Elements in the WAF1/Cip1/p21 Promoter (*) , 1995, The Journal of Biological Chemistry.
[26] J. Leiden,et al. Adenovirus-mediated over-expression of the cyclin/cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty. , 1995, The Journal of clinical investigation.
[27] K. Walsh,et al. Regulation of Gax homeobox gene transcription by a combination of positive factors including myocyte-specific enhancer factor 2 , 1995, Molecular and cellular biology.
[28] David O. Morgan,et al. Principles of CDK regulation , 1995, Nature.
[29] Paul Nurse,et al. Ordering S phase and M phase in the cell cycle , 1994, Cell.
[30] C. Sherr. G1 phase progression: Cycling on cue , 1994, Cell.
[31] J. Miano,et al. Localization of Fos and Jun proteins in rat aortic smooth muscle cells after vascular injury. , 1993, The American journal of pathology.
[32] J. Miano,et al. Early proto-oncogene expression in rat aortic smooth muscle cells following endothelial removal. , 1990, The American journal of pathology.
[33] K. Karsch,et al. Time course of smooth muscle cell proliferation in the intima and media of arteries following experimental angioplasty. , 1990, Circulation research.
[34] H. Harris,et al. Expression of a human placental alkaline phosphatase gene in transfected cells: use as a reporter for studies of gene expression. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[35] M. Reidy,et al. Kinetics of cellular proliferation after arterial injury. III. Endothelial and smooth muscle growth in chronically denuded vessels. , 1986, Laboratory investigation; a journal of technical methods and pathology.
[36] S. Schwartz,et al. Significance of Quiescent Smooth Muscle Migration in the Injured Rat Carotid Artery , 1985, Circulation research.
[37] M. Reidy,et al. Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium. , 1983, Laboratory investigation; a journal of technical methods and pathology.
[38] J. Rowe,et al. Vascular smooth muscle cell growth kinetics in vivo in aged rats. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[39] M. Adams,et al. Time course of cellular proliferation, intimal hyperplasia, and remodeling following angioplasty in monkeys with established atherosclerosis. A nonhuman primate model of restenosis. , 1996, Arteriosclerosis, thrombosis, and vascular biology.